Cargando…

P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)

Detalles Bibliográficos
Autores principales: LI, Chunrui, Wang, DI, Song, Yongping, Huang, He, LI, Jianyong, Chen, Bing, Liu, Jing, Dong, Yujun, Hu, Kai, Liu, Peng, Zhang, XI, MI, Jianqing, LI, Zhenyu, Ding, Kaiyang, Xu, Aining, Cai, Songbai, Guo, Jingjing, Gui, Hongyu, Wang, Wen, Qiu, Lugui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431138/
http://dx.doi.org/10.1097/01.HS9.0000970372.45392.b8
_version_ 1785091129743507456
author LI, Chunrui
Wang, DI
Song, Yongping
Huang, He
LI, Jianyong
Chen, Bing
Liu, Jing
Dong, Yujun
Hu, Kai
Liu, Peng
Zhang, XI
MI, Jianqing
LI, Zhenyu
Ding, Kaiyang
Xu, Aining
Cai, Songbai
Guo, Jingjing
Gui, Hongyu
Wang, Wen
Qiu, Lugui
author_facet LI, Chunrui
Wang, DI
Song, Yongping
Huang, He
LI, Jianyong
Chen, Bing
Liu, Jing
Dong, Yujun
Hu, Kai
Liu, Peng
Zhang, XI
MI, Jianqing
LI, Zhenyu
Ding, Kaiyang
Xu, Aining
Cai, Songbai
Guo, Jingjing
Gui, Hongyu
Wang, Wen
Qiu, Lugui
author_sort LI, Chunrui
collection PubMed
description
format Online
Article
Text
id pubmed-10431138
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311382023-08-17 P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) LI, Chunrui Wang, DI Song, Yongping Huang, He LI, Jianyong Chen, Bing Liu, Jing Dong, Yujun Hu, Kai Liu, Peng Zhang, XI MI, Jianqing LI, Zhenyu Ding, Kaiyang Xu, Aining Cai, Songbai Guo, Jingjing Gui, Hongyu Wang, Wen Qiu, Lugui Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431138/ http://dx.doi.org/10.1097/01.HS9.0000970372.45392.b8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
LI, Chunrui
Wang, DI
Song, Yongping
Huang, He
LI, Jianyong
Chen, Bing
Liu, Jing
Dong, Yujun
Hu, Kai
Liu, Peng
Zhang, XI
MI, Jianqing
LI, Zhenyu
Ding, Kaiyang
Xu, Aining
Cai, Songbai
Guo, Jingjing
Gui, Hongyu
Wang, Wen
Qiu, Lugui
P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
title P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
title_full P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
title_fullStr P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
title_full_unstemmed P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
title_short P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
title_sort p867: ct103a, a novel fully human bcma-targeting car-t cells in patients with relapsed/refractory multiple myeloma: updated results of phase 1b/2 study (fumanba-1)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431138/
http://dx.doi.org/10.1097/01.HS9.0000970372.45392.b8
work_keys_str_mv AT lichunrui p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT wangdi p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT songyongping p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT huanghe p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT lijianyong p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT chenbing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT liujing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT dongyujun p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT hukai p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT liupeng p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT zhangxi p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT mijianqing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT lizhenyu p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT dingkaiyang p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT xuaining p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT caisongbai p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT guojingjing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT guihongyu p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT wangwen p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1
AT qiulugui p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1